Literature DB >> 11357935

Identification and characterization of trypanocides by functional expression of an adenosine transporter from Trypanosoma brucei in yeast.

P Mäser1, D Vogel, C Schmid, B Räz, R Kaminsky.   

Abstract

The causative agents of sleeping sickness, Trypanosoma brucei rhodesiense and T. brucei gambiense, do not synthesize purines de novo but salvage purine bases and nucleosides from their hosts. We used yeast as an expression system for functional characterization of the trypanosomal adenosine transporter TbAT1. A selection of purine analogs and flavonoids were tested for their ability to interfere with adenosine transport, with the aims of identifying (a) trypanocidal TbAT1 substrates, and (b) inhibitors of trypanosomal purine transport. Cordycepin (3'-deoxyadenosine) was a TbAT1 substrate of high activity against T. brucei rhodesiense (IC50 0.2 nM). Inhibitors of mammalian nucleoside transport were not active, while the flavonol silibinin was a potent, noncompetitive inhibitor of TbAT1-mediated adenosine transport in yeast. Silibinin also inhibited melarsen-induced lysis of bloodstream form trypanosomes. IC50 values to T. brucei rhodesiense and to human carcinoma cells were 0.6 and 140 microM, respectively, indicating a good selectivity towards the parasites. Further studies are necessary to elucidate the effects of flavonoids on trypanosomal purine transport and their potential as trypanocides.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11357935     DOI: 10.1007/s001090000169

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  6 in total

1.  Structures of adenosine kinase from Trypanosoma brucei brucei.

Authors:  Jennifer Timm; Dolores González-Pacanowska; Keith S Wilson
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2013-12-24       Impact factor: 1.056

2.  Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.

Authors:  Fernanda Karoline Vieira da Silva Torchelsen; Thaila Martins Silva; Matheus Marques Milagre; Rafael Rodrigues Silva; Levi Eduardo Soares Reis; Renata Tupinambá Branquinho; Glenda Nicioli Silva; Marta de Lana
Journal:  Parasitol Res       Date:  2020-11-24       Impact factor: 2.289

3.  Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.

Authors:  Enock Matovu; Mhairi L Stewart; Federico Geiser; Reto Brun; Pascal Mäser; Lynsey J M Wallace; Richard J Burchmore; John C K Enyaru; Michael P Barrett; Ronald Kaminsky; Thomas Seebeck; Harry P de Koning
Journal:  Eukaryot Cell       Date:  2003-10

4.  Adenosine kinase of Trypanosoma brucei and its role in susceptibility to adenosine antimetabolites.

Authors:  Alexandra Lüscher; Pinar Onal; Anne-Marie Schweingruber; Pascal Mäser
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

5.  Synergistic antibacterial effect between silibinin and antibiotics in oral bacteria.

Authors:  Young-Soo Lee; Kyeung-Ae Jang; Jeong-Dan Cha
Journal:  J Biomed Biotechnol       Date:  2011-09-15

6.  Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein.

Authors:  Jane C Munday; Daniel N A Tagoe; Anthonius A Eze; Jessica A M Krezdorn; Karla E Rojas López; Abdulsalam A M Alkhaldi; Fiona McDonald; Jennifer Still; Khalid J Alzahrani; Luca Settimo; Harry P De Koning
Journal:  Mol Microbiol       Date:  2015-03-21       Impact factor: 3.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.